Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Completed × Thalidomide × Clear all

Phase

Phase 2 88 Phase 3 31 Phase 1 8 Phase 1/2 7 Phase 2/3 3 Phase NA 2 Phase 4 1

Status

Unknown 5 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Waldenstrom Macroglobulinemia 1

Interventions

Metformin 23 Saline Solution 22 Zoledronic Acid 21 Dexamethasone 19 Cytarabine 18 Cyclophosphamide 18 Bupivacaine 16 Propofol 15 Sodium Chloride 14 Morphine 14 Methotrexate 14 Letrozole 14 Vincristine 13 Fentanyl 13 Dexmedetomidine 13 Imiquimod 12 Docetaxel 12 Prednisolone 11 Mercaptopurine 11 Doxorubicin 11 Oxycodone 10 Everolimus 10 Capecitabine 10 Bevacizumab 10 Acetaminophen 10 nilotinib 9 enzalutamide 9 Ropivacaine 9 Rituximab 9 Lidocaine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02844309 2026-02-11

BDH-WM02

Institute of Hematology & Blood Diseases Hospital, China

Phase 4 Completed

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡